Hoyoku Nishino Selected Research

Hoyoku Nishino Research Topics

Disease

86	Neoplasms (Cancer) 02/2014 - 01/2000
47	Carcinogenesis 11/2013 - 01/2000
8	Inflammation (Inflammations) 01/2015 - 02/2002
7	Papilloma (Papillomatosis) 04/2008 - 06/2002
6	Hepatocellular Carcinoma (Hepatoma) 03/2009 - 01/2004
6	Osteonecrosis (Kienbock's Disease) 07/2008 - 01/2003
4	Colonic Neoplasms (Colon Cancer) 06/2007 - 01/2002
3	Adenocarcinoma 11/2013 - 02/2002
3	Lung Neoplasms (Lung Cancer) 02/2012 - 04/2004
3	Hepatitis 03/2009 - 01/2007
3	Liver Neoplasms (Liver Cancer) 03/2009 - 01/2004
3	Fibrosis (Cirrhosis) 03/2009 - 01/2007
2	Abdominal Obesity 07/2015 - 12/2010
2	Obesity 07/2015 - 12/2010
2	Adenoma (Adenomas) 11/2013 - 02/2002
2	Prostatic Neoplasms (Prostate Cancer) 11/2004 - 05/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2004 - 02/2002
2	Neoplasm Metastasis (Metastasis) 01/2004 - 09/2002
2	Carcinoma (Carcinomatosis) 09/2002 - 02/2002
1	Muscular Atrophy (Muscle Atrophy) 03/2021
1	Atrophy 04/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016
1	Atherosclerosis 01/2016
1	Hypercholesterolemia 01/2016
1	Non-alcoholic Fatty Liver Disease 12/2015
1	Colorectal Neoplasms (Colorectal Cancer) 02/2014
1	Polyps 02/2014
1	Foreign Bodies (Foreign Body) 11/2013

Drug/Important Bio-Agent (IBA)

18	Epstein-Barr virus early antigenIBA 01/2009 - 02/2002
15	Carotenoids (Carotene)IBA 02/2014 - 01/2000
14	anthraceneIBA 01/2009 - 02/2002
13	CarcinogensIBA 09/2013 - 02/2002
10	Peroxynitrous Acid (Peroxynitrite)IBA 01/2009 - 02/2002
9	TriterpenesIBA 08/2007 - 03/2002
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2013 - 09/2002
6	isoliquiritigenin (GU 17)IBA 01/2006 - 02/2002
5	PhytochemicalsIBA 01/2009 - 01/2000
5	SteroidsIBA 07/2008 - 12/2002
5	AcidsIBA 06/2007 - 02/2002
5	FlavonoidsIBA 11/2005 - 05/2003
4	fucoxanthinIBA 03/2021 - 01/2002
4	LactoferrinIBA 01/2016 - 12/2010
4	Phosphates (Orthophosphate)IBA 09/2006 - 11/2003
4	BuffersIBA 09/2006 - 11/2003
4	9,10-Dimethyl-1,2-benzanthraceneIBA 02/2004 - 02/2003
3	TabletsIBA 07/2015 - 12/2010
3	nobiletinIBA 09/2013 - 01/2004
3	cucurbitaneIBA 08/2007 - 02/2002
3	AlkaloidsIBA 01/2006 - 03/2002
3	CoumarinsIBA 03/2005 - 02/2002
3	AzoxymethaneIBA 05/2004 - 02/2002
3	GlycosidesIBA 07/2003 - 02/2002
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2021 - 12/2002
2	CholesterolIBA 01/2016 - 02/2014
2	Transcription Factors (Transcription Factor)IBA 01/2015 - 07/2003
2	ZeaxanthinsIBA 02/2014 - 01/2002
2	beta Carotene (Betacarotene)FDA Link 02/2014 - 01/2002
2	LuteinIBA 02/2014 - 01/2002
2	alpha-caroteneIBA 02/2014 - 01/2002
2	Nitric Oxide Synthase (NO Synthase)IBA 11/2013 - 01/2004
2	capsanthinIBA 02/2012 - 01/2002
2	Pharmaceutical PreparationsIBA 02/2012 - 01/2008
2	Biomarkers (Surrogate Marker)IBA 03/2010 - 11/2005
2	Beta-CryptoxanthinIBA 03/2009 - 01/2002
2	Proteins (Proteins, Gene)FDA Link 03/2009 - 09/2007
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2008 - 03/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2007 - 08/2005
2	LigandsIBA 06/2007 - 08/2005
2	Glycerol (Glycerine)FDA LinkGeneric 12/2006 - 03/2003
2	Emodin (Archin)IBA 09/2006 - 08/2002
2	EnzymesIBA 01/2006 - 11/2005
2	RNA (Ribonucleic Acid)IBA 11/2005 - 02/2002
2	LuteolinIBA 11/2005 - 08/2005
2	Glycyrrhetinic Acid (Po 12)IBA 11/2005 - 02/2003
2	monascinIBA 10/2005 - 02/2005
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 07/2004 - 07/2003
2	deguelinIBA 06/2004 - 01/2004
2	alpha-toxicarolIBA 06/2004 - 01/2004
2	Dinoprostone (PGE2)FDA Link 05/2004 - 01/2004
2	AntioxidantsIBA 01/2004 - 06/2002
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 11/2003 - 02/2003
2	NaphthoquinonesIBA 11/2003 - 02/2003
2	glycerolglycolipidsIBA 03/2003 - 12/2002
2	TeaIBA 02/2003 - 04/2002
2	AntigensIBA 02/2003 - 02/2002
2	XanthonesIBA 02/2003 - 03/2002
2	LycopeneIBA 03/2002 - 01/2002
1	fucoxanthinolIBA 04/2020
1	Triglycerides (Triacylglycerol)IBA 04/2020
1	Glycoproteins (Glycoprotein)IBA 12/2015
1	Analgesics (Analgesic Drugs)IBA 01/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	AntipyreticsIBA 01/2015
1	NF-kappa B (NF-kB)IBA 01/2015
1	Caspase 3 (Caspase-3)IBA 11/2013
1	pimagedine (aminoguanidine)IBA 11/2013

Therapy/Procedure

7	Chemoprevention 01/2007 - 01/2000
5	Oral Administration 03/2021 - 02/2003
5	Therapeutics 06/2007 - 04/2004
3	Kidney Transplantation 05/2007 - 11/2003